Record title

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial

Record identifier

TN_cdi_proquest_miscellaneous_1751228383

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751228383

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial

About this item

Full title

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2014, Vol.15 (11), p.1269-1278

Record Identifier

TN_cdi_proquest_miscellaneous_1751228383

Language

English

Formats

Publication information

Publisher

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1751228383

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751228383

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item